Bristol-Myers Squibb Medical Imaging

13.10.2006 – 16:34
Bristol-Myers Squibb Medical Imaging Receives European Commission Marketing Authorisation for its Ultrasound Contrast Agent Luminity(TM)(Perflutren Lipid Microsphere)
N. Billerica, Massachusetts (ots/PRNewswire) - Bristol-Myers Squibb Medical Imaging announced today that the European Commission has granted marketing authorisation for LUMINITY(TM), an ultrasound contrast agent, for use in patients with suboptimal echocardiograms who have suspected or established ...
plus
11.10.2006 – 09:01
/K I L L K I L L K I L L -- Bristol-Myers Squibb Medical Imaging/
Journalists and other readers should disregard the news release "Bristol-Myers Squibb Medical Imaging Receives European Commission Marketing Authorisation for Its Ultrasound Contrast Agent LUMINITY(TM) (perflutren lipid microsphere)" NYSE:BMY, issued earlier today. The release was issued prematurely by PR Newswire. ots Originaltext: Bristol-Myers Squibb Medical ...
plus
11.10.2006 – 08:33
Bristol-Myers Squibb Medical Imaging Receives European Commission Marketing Authorisation for Its Ultrasound Contrast Agent LUMINITY(TM) (perflutren lipid microsphere)
N. Billerica, Massachusetts (ots/PRNewswire) - Bristol-Myers Squibb Medical Imaging announced today that the European Commission has granted marketing authorisation for LUMINITY(TM), an ultrasound contrast agent, for use in patients with suboptimal echocardiograms who have suspected or established ...
plus